Transgene Biotek informs about outcome of board meeting

23 Jan 2021 Evaluate

Transgene Biotek has informed that at the meeting of the board of directors of the company held on 23rd January 2021 has approved the Unaudited Standalone and Consolidated Financial Results along with Limited Review Report of the Company for the quarter ended on 31st December 2020.

The above information is a part of company’s filings submitted to BSE.

Transgene Biotek Share Price

6.77 0.22 (3.36%)
10-May-2024 16:01 View Price Chart
Peers
Company Name CMP
Aster DM Healthcare 344.50
Apollo Hospital Ent. 5837.15
Max Healthcare Inst 810.00
Narayana Hrudayalay 1260.00
Global Health 1410.90
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.